Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript
Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.
Source: insidermonkey.com
Thomas Glanzmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Glanzmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Glanzmann Today - Breaking & Trending Today
Grifols S A : on track to close its strategic alliance with Haier in first half 2024 May 6 2024
Grifols on track to close its strategic alliance with Haier in first half 2024 Both companies have completed the customary...
Source: marketscreener.com
Grifols S A : announces signing of private offering of EUR 1 billion senior secured notes due 2030 April 23 2024
Grifols announces signing of private offering of EUR 1 billion senior secured notes due 2030 Barcelona, Spain, April 23, 2024 - Grifols , a global healthcare...
Source: marketscreener.com
Grifols celebrates 50 years in Clayton | North Carolina Biotechnology Center
Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC.Grifols acquired the Johnston County facility in 2011 from Talecris Biotherapeutics, turning Grifols into a top-three plasma-sector powerhouse.
Source: ncbiotech.org
Grifols says it is on track to lower its debt ratio
Grifols said on Thursday it had lowered its debt ratio in 2023 and was on track to reduce it further using funds from the $1.8 billion sale of its stake in Shanghai RAAS Blood Products which is...
Source: marketscreener.com